{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:32:59Z","timestamp":1791919979816,"version":"4.3.4"},"reference-count":66,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ7\/01758"],"award-info":[{"award-number":["2016\/21\/B\/NZ7\/01758"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Naturally occurring pentacyclic triterpenoid oleanolic acid (OA) serves as a good scaffold for additional modifications to achieve synthetic derivatives. Therefore, a large number of triterpenoids have been synthetically modified in order to increase their bioactivity and their protective or therapeutic effects. Moreover, attempts were performed to conjugate synthetic triterpenoids with non-steroidal anti-inflammatory drugs (NSAIDs) or other functional groups. Among hundreds of synthesized triterpenoids, still the most promising is 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), which reached clinical trials level of investigations. The new group of synthetic triterpenoids are OA oximes. The most active among them is 3-hydroxyiminoolean-12-en-28-oic acid morpholide, which additionally improves the anti-cancer activity of standard NSAIDs. While targeting the Nrf2 and NF-\u03baB signaling pathways is the main mechanism of synthetic OA derivatives\u2032 anti-inflammatory and anti-cancer activity, most of these compounds exhibit multifunctional activity, and affect cross-talk within the cellular signaling network. This short review updates the earlier data and describes the new OA derivatives and their conjugates in the context of modification of signaling pathways involved in inflammation and cell survival and subsequently in cancer development.<\/jats:p>","DOI":"10.3390\/molecules26164957","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T21:27:45Z","timestamp":1629149265000},"page":"4957","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Anti-Cancer Potential of Synthetic Oleanolic Acid Derivatives and Their Conjugates with NSAIDs"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-5343","authenticated-orcid":false,"given":"Wanda","family":"Baer-Dubowska","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 4, \u015awi\u0119cicki Street, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-2079","authenticated-orcid":false,"given":"Maria","family":"Naro\u017cna","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 4, \u015awi\u0119cicki Street, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-0298","authenticated-orcid":false,"given":"Violetta","family":"Krajka-Ku\u017aniak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 4, \u015awi\u0119cicki Street, 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1021\/jf102039t","article-title":"Pentacyclic triterpenoids from olive fruit and leaf","volume":"58","author":"Guinda","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/molecules14062016","article-title":"Pentacyclic triterpene distribution in various plants-rich sources for a new group of multi-potent plant extracts","volume":"14","author":"Trojan","year":"2009","journal-title":"Molecules"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phytochem.2011.12.022","article-title":"Oleanolic acid","volume":"77","author":"Pollier","year":"2012","journal-title":"Phytochemistry"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pawe\u0142czyk, A., Olender, D., Sowa-Kasprzak, K., and Zaprutko, L. (2016). Hybrid compounds strategy in the synthesis of oleanolic acid skeleton-NSAID derivatives. Molecules, 21.","DOI":"10.3390\/molecules21040420"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: Pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/pr.111.004846","article-title":"Synthetic oleanane triterpenoids: Multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease","volume":"64","author":"Liby","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nrclinonc.2012.120","article-title":"Cancer prevention by targeting angiogenesis","volume":"9","author":"Albini","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: Molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"ref_9","first-page":"610","article-title":"Repurposing Drugs in Oncology (ReDO)-Diclofenac as an anti-cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"eCancerMedicalscience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: Mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","first-page":"a000067","article-title":"Specification of DNA binding activity of NF-kappaB proteins","volume":"4","author":"Wan","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_16","first-page":"145","article-title":"Nuclear Factor Kappa B Signaling Complexes in Acute Inflammation","volume":"3","author":"Monsalve","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pires, B.R.B., Silva, R.C.M.C., Ferreira, G.M., and Abdelhay, E. (2018). NF-kappaB: Two Sides of the Same Coin. Genes, 9.","DOI":"10.3390\/genes9010024"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","article-title":"Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere","volume":"11","author":"Verzella","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently Activated Stat3 Maintains Constitutive NF-\u03baB Activity in Tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/hep.25900","article-title":"The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BIM in mice","volume":"56","author":"Yu","year":"2012","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., and Perumal, E. (2018). Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance. Cancers, 12.","DOI":"10.3390\/cancers10120481"},{"key":"ref_23","first-page":"393","article-title":"The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment","volume":"3","author":"Paluszczak","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"9","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fphar.2019.00287","article-title":"A computational model of tumor growth and anakoinosis","volume":"10","author":"Pantziarka","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3329\/bjp.v10i4.23709","article-title":"Anti-cancer activity of novel oleanolic acid methyl ester derivative in HeLa cervical cancer cells is mediated through apoptosis induction and reactive oxygen species production","volume":"10","author":"Song","year":"2015","journal-title":"Bangladesh J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.3390\/molecules18033615","article-title":"Efficient synthesis and anti-fungal activity of oleanolic acid oxime esters","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejps.2012.07.017","article-title":"The analgesic and anti-inflammatory effect of new oleanolic acid acyloxyimino derivative","volume":"47","author":"Zaprutko","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_30","first-page":"237","article-title":"Oleanane derivatives for pharmaceutical use: A patent review (2000-2016)","volume":"3","author":"Masullo","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1940-6207.CAPR-10-0197","article-title":"Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer","volume":"3","author":"Liby","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc2129","article-title":"Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer","volume":"5","author":"Liby","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/0008-5472.CAN-06-4534","article-title":"The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A\/J mice","volume":"67","author":"Liby","year":"2007","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.bmcl.2013.01.129","article-title":"Synthesis and cytotoxicity evaluation of oleanolic acid derivatives","volume":"23","author":"Hao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103326","DOI":"10.1016\/j.bioorg.2019.103326","article-title":"Oleanolic acid oxime derivatives and their conjugates with aspirin modulate the NF-\u03baB-mediated transcription in HepG2 hepatoma cells","volume":"93","author":"Paluszczak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/prot.21367","article-title":"EADock: Docking of small molecules into protein active sites with a multiobjective evolutionary optimization","volume":"67","author":"Grosdidier","year":"2007","journal-title":"Proteins"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1021\/acs.jmedchem.0c01088","article-title":"CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1","volume":"63","author":"Meng","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_38","first-page":"215","article-title":"In silico Evidence for Binding of Pentacyclic Triterpenoids to Keap1-Nrf2 Protein-Protein Binding Site","volume":"20","author":"Kamble","year":"2017","journal-title":"Comb. Chem. Highthroughput Screen."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Naro\u017cna, M., Krajka-Ku\u017aniak, V., Bednarczyk-Cwynar, B., Kuci\u0144ska, M., Kleszcz, R., Kujawski, J., Piotrowska-Kempisty, H., Plewi\u0144ski, A., Murias, M., and Baer-Dubowska, W. (2021). Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-\u03baB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential. Pharmaceuticals, 14.","DOI":"10.3390\/ph14070688"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1021\/acsomega.8b01034","article-title":"Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids","volume":"3","author":"Garrido","year":"2018","journal-title":"ACS Omega"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Patil, K.R., Mohapatra, P., Patel, H.M., Goyal, S.N., Ojha, S., Kundu, C.N., and Patil, C.R. (2015). Pentacyclic Triterpenoids Inhibit IKK\u03b2 Mediated Activation of NF-\u03baB Pathway: In Silico and In Vitro Evidences. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125709"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1535-7163.MCT-06-0444","article-title":"The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta","volume":"5","author":"Yore","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/sj.leu.2403328","article-title":"CDDO induces apoptosis via the intrinsic pathway in lymphoid cells","volume":"18","author":"Inoue","year":"2004","journal-title":"Leukemia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2006-11-058941","article-title":"CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer-binding protein alpha","volume":"110","author":"Koschmieder","year":"2007","journal-title":"Blood"},{"key":"ref_45","first-page":"336","article-title":"A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity","volume":"59","author":"Suh","year":"1999","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-05-2044","article-title":"A Synthetic Triterpenoid, CDDO-Me, Inhibits IKBA Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor KB Regulated Gene Products in Human Leukemic Cells","volume":"12","author":"Shishodia","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Borella, R., Forti, L., Gibellini, L., De Gaetano, A., De Biasi, S., Nasi, M., Cossarizza, A., and Pinti, M. (2019). Synthesis and anticancer activity of CDDO and CDDO-me, two derivatives of natural triterpenoids. Molecules, 24.","DOI":"10.3390\/molecules24224097"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1167\/iovs.09-3648","article-title":"Synthetic triterpenoids attenuate cytotoxic retinal injury: Cross-talk between Nrf2 and PI3K\/AKT signaling through inhibition of the lipid phosphatase PTEN","volume":"50","author":"Liby","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Liby","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-4598-13-30","article-title":"Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment","volume":"13","author":"Wang","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbamcr.2017.03.012","article-title":"Synthetic triterpenoids inhibit GSK3\u03b2 activity and localization and affect focal adhesions and cell migration","volume":"1864","author":"To","year":"2017","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"ref_52","first-page":"31","article-title":"CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated anti-apoptotic and proangiogenic proteins in TRAMP prostate cancer cells","volume":"7","author":"Deeb","year":"2008","journal-title":"J. Exp. Ther. Oncol."},{"key":"ref_53","first-page":"2075","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: An update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_54","unstructured":"(2021, May 19). C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use. Available online: https:\/\/patents.google.com\/patent\/MX2015003078A\/en."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"173307","DOI":"10.1016\/j.ejphar.2020.173307","article-title":"Activation of the Nrf2 response by oleanolic acid oxime morpholide (3-hydroxyiminoolean-12-en-28-oic acid morpholide) is associated with its ability to induce apoptosis and inhibit proliferation in HepG2 hepatoma cells","volume":"883","author":"Kleszcz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_56","unstructured":"(2021, May 19). CDDO-Me Amino Acid Conjugates and Methods of Use. Available online: https:\/\/patents.google.com\/patent\/US9290455B2\/en."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3892\/or.2020.7666","article-title":"Mechanistic investigations of antitumor activity of a Rhodamine B-oleanolic acid derivative bioconjugate","volume":"44","author":"Macasoi","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13065-016-0217-5","article-title":"Synthesis of acyl oleanolic acid-uracil conjugates and their anti-tumor activity","volume":"10","author":"Mo","year":"2016","journal-title":"Chem. Cent. J."},{"key":"ref_59","first-page":"3418975","article-title":"Role of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion","volume":"2019","author":"Wong","year":"2019","journal-title":"Adv. Pharmacol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4155\/fmc-2020-0109","article-title":"Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents","volume":"12","author":"Panda","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_61","first-page":"202","article-title":"Strong and Long-Lasting Antinociceptive and Anti-inflammatory Conjugate of Naturally Occurring Oleanolic Acid and Aspirin","volume":"7","author":"Wachowiak","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Naro\u017cna, M., Krajka-Ku\u017aniak, V., Bednarczyk-Cwynar, B., Kleszcz, R., and Baer-Dubowska, W. (2020). The Effect of Novel Oleanolic Acid Oximes Conjugated with Indomethacin on the Nrf2-ARE And NF-\u03baB Signaling Pathways in Normal Hepatocytes and Human Hepatocellular Cancer Cells. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010032"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1089\/ars.2010.3216","article-title":"When NRF2 talks, who\u2019s listening?","volume":"13","author":"Wakabayashi","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lee, K., Kim, S., Lee, Y., Lee, H., Lee, Y., Park, H., Nahm, J.H., Ahn, S., Yu, S.J., and Lee, K. (2020). The clinicopathological and prognostic significance of nrf2 and keap1 expression in hepatocellular carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12082128"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/carcin\/bgt108","article-title":"Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402\/ADM cells to doxorubicin via inhibiting PI3K\/Akt\/Nrf2 pathway","volume":"34","author":"Gao","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cbi.2013.08.008","article-title":"Chrysin enhances sensitivity of BEL-7402\/ADM cells to doxorubicin by suppressing PI3K\/Akt\/Nrf2 and ERK\/Nrf2 pathway","volume":"206","author":"Gao","year":"2013","journal-title":"Chem. Biol. Interact."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/16\/4957\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:08Z","timestamp":1760165228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/16\/4957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":66,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["molecules26164957"],"URL":"https:\/\/doi.org\/10.3390\/molecules26164957","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}